FDMT Stock-Based Compensation
4D Molecular Therapeutics Inc · Stock-Based Compensation
FDMT Stock-Based Compensation
Latest reported$5.88Mperiod ending
FDMT Quarterly Stock-Based Comp ($201.50K → $5.88M)
Quarterly stock-based compensation
High-resolution chart · PNG
FDMT stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,884,000 | |
| 4,453,000 | |
| 5,553,000 | |
| 4,519,000 | |
| 4,958,000 | |
| 6,986,000 | |
| 7,578,000 | |
| 6,490,000 | |
| 6,073,000 | |
| 5,974,000 | |
| 5,913,000 | |
| 4,562,000 | |
| 4,969,000 | |
| 4,221,000 | |
| 4,346,000 | |
| 4,520,000 | |
| 4,322,000 | |
| 3,933,000 | |
| 3,731,000 | |
| 3,923,000 | |
| 3,816,000 | |
| 2,329,000 | |
| 1,717,000 | |
| 1,147,000 | |
| 1,037,000 | |
| 1,083,000 | |
| 1,015,000 | |
| 1,054,000 | |
| 736,000 | |
| 736,000 | |
| 487,000 | |
| 487,000 | |
| 201,500 | |
| 201,500 |